CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (USD $) In Millions, except Per Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME
Product revenue	$ 1,556.5	$ 1,445.6	$ 1,145.4
Service revenue	210.0	194.8	151.1
Other revenue	24.9	11.3	8.4
Total revenue	1,791.4	1,651.7	1,304.9
Cost of product revenue	839.0	792.5	621.5
Cost of service revenue	121.0	106.7	79.4
Total cost of revenue	960.0	899.2	700.9
Gross profit	831.4	752.5	604.0
Operating expenses:
Selling, general and administrative	442.4	406.6	301.1
Research and development	195.3	177.2	141.4
Impairment of assets	23.8
Write-off of deferred offering costs		3.4
Other charges, net	13.9	9.7	5.8
Total operating expenses	675.4	596.9	448.3
Operating income	156.0	155.6	155.7
Interest and other income (expense), net	(17.7)	(10.1)	(5.6)
Income before income taxes and noncontrolling interest in consolidated subsidiaries	138.3	145.5	150.1
Income tax provision	60.1	51.5	53.3
Consolidated net income	78.2	94.0	96.8
Net income attributable to noncontrolling interest in consolidated subsidiaries	0.7	1.7	1.4
Net income attributable to Bruker Corporation	77.5	92.3	95.4
Net income per common share attributable to Bruker Corporation shareholders:
Basic (in dollars per share)	$ 0.47	$ 0.56	$ 0.58
Diluted (in dollars per share)	$ 0.46	$ 0.55	$ 0.58
Weighted average common shares outstanding:
Basic (in shares)	166.0	165.4	164.4
Diluted (in shares)	167.4	166.9	165.7
Consolidated net income	78.2	94.0	96.8
Foreign currency translation adjustments	8.8	(14.7)	8.1
Changes in hedging instruments	1.1	1.9	0.5
Pension liability adjustments (net of tax of $3.7 million, $0.6 million and $2.6 million, respectively)	(15.0)	2.9	(9.9)
Net comprehensive income	73.1	84.1	95.5
Less: Comprehensive income attributable to noncontrolling interests	0.3	1.7	1.2
Comprehensive income attributable to Bruker Corporation	$ 72.8	$ 82.4	$ 94.3